PRICKLE1 and breast carcinoma: Altogether, these data demonstrate the importance of PRICKLE1 and its associated protein complex as poor-prognosis markers in TNBC and provide evidence that PRICKLE1 may be a suitable therapeutic target for treatment of this aggressive subtype of breast cancer.